US Broker Ratings

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook Reveals 8.80% Upside Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $891.56 million, this biopharmaceutical..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 28.66% Potential Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology industry, offers a compelling investment opportunity amidst the dynamic healthcare sector. With a market capitalization of $4.39 billion, ACADIA..

Sotera Health Company (SHC) Stock Analysis: Evaluating a 13.64% Potential Upside and Strong Buy Ratings

Sotera Health Company (NASDAQ: SHC) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $5.13 billion, this Ohio-based..

Mirum Pharmaceuticals (MIRM) Stock Analysis: Unpacking a 40% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biotech sector with its focus on developing therapies for rare and debilitating diseases. With a market capitalization of $6.38 billion,..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Significant Upside Potential with 138% Growth Prospects

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its promising growth potential in the healthcare sector. Headquartered in Durham, North Carolina, BioCryst specializes in developing and..

MiMedx Group, Inc (MDXG) Stock Analysis: Unpacking a 54% Potential Upside in Biotech

MiMedx Group, Inc. (NASDAQ: MDXG) stands as a compelling figure in the biotech sector, boasting a market capitalization of $622.4 million. Specializing in the development and distribution of placental tissue..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: What Investors Need to Know About Its 44.7% Revenue Growth

Investors have shown increasing interest in Establishment Labs Holdings Inc (NASDAQ: ESTA) as the company continues to make waves in the healthcare sector, particularly within the medical devices industry. Specializing..

IDEAYA Biosciences (IDYA) Stock Analysis: Unpacking a 51% Potential Upside with Strong Buy Ratings

IDEAYA Biosciences, Inc. (IDYA), a prominent player in the biotechnology sector, is capturing investor attention with its innovative precision medicine oncology solutions and a robust market cap of $3.41 billion...

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering a 16.68% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) presents an intriguing opportunity for investors with its focus on groundbreaking therapies for autoimmune diseases. Based in Edmonton, Canada, this biopharmaceutical company has carved a..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A 43.66% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its promising growth prospects and a substantial potential upside. With a market capitalization..

agilon health, inc. (AGL) Stock Analysis: Navigating Challenges with Strategic Insights

agilon health, inc. (NYSE: AGL), a key player in the medical care facilities sector, is facing a turbulent market environment. With a market capitalization of $1.57 billion, this Ohio-based company..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 21% Upside Potential

UFP Technologies, Inc. (NASDAQ: UFPT) has become a compelling contender in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.07 billion and a diverse..

Mineralys Therapeutics (MLYS) Stock Analysis: Exploring a 90% Potential Upside in the Biotech Space

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a burgeoning name in the biotechnology sector focused on addressing diseases driven by dysregulated aldosterone, has been making waves with its promising drug development pipeline...

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 38% Potential Upside

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, is capturing investor attention with its impressive growth prospects and strategic focus on central nervous system (CNS) diseases. With..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Evaluating the Healthcare Specialist with a Strong ROE and Market Position

Pediatrix Medical Group, Inc. (NYSE: MD), a significant player in the U.S. healthcare sector, specifically within medical care facilities, presents an intriguing proposition for investors seeking exposure in the healthcare..

Progyny, Inc. (PGNY) Stock Analysis: Unpacking Growth Potential with a 7.83% Upside

Progyny, Inc. (NASDAQ: PGNY) is capturing investor attention as a unique player in the healthcare sector, specifically within the healthcare plans industry. With a market capitalization of $2.47 billion, this..

Evotec SE (EVO) Stock Analysis: Unveiling Nearly 100% Upside Potential Amidst Strong Strategic Collaborations

Evotec SE (EVO), a prominent player in the healthcare sector, primarily operates in the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, the company is renowned for its..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Healthcare Diagnostics Frontier with a Market Cap of $3.02 Billion

GRAIL, Inc. (NASDAQ: GRAL) stands as a prominent player in the healthcare sector, specializing in diagnostics and research. With its core offering, Galleri—a multi-cancer early detection test—GRAIL is revolutionizing cancer..

Liquidia Corporation (LQDA) Stock Analysis: Exploring Growth Potential in Rare Cardiopulmonary Therapeutics

Liquidia Corporation (NASDAQ: LQDA) is making waves in the healthcare sector with its significant advancements in the treatment of rare cardiopulmonary diseases. Trading at $83.85, the company has captured the..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 20% Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH) is drawing investor interest as it stands at the crossroads of healthcare and industrial injury prevention services. This Houston-based company, with a market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds